2022
DOI: 10.5409/wjcp.v11.i2.136
|View full text |Cite
|
Sign up to set email alerts
|

Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 100 publications
0
3
0
Order By: Relevance
“…Narkewicz et al characterized 63 children with acute liver failure caused by AIH and found LKM antibodies in 15 of them (24%), 12 having LKM alone, 3 LKM and ANA, and 2 LKM and smooth muscle antibodies [ 6 ]. Muratori et al studied 21 patients with type 2 AIH and demonstrated that 7 of those were positive for LKM1 (33%), 9 for LC1 and 5 for both [ 13 ]. More recently, Khayat et al found LKM antibodies in 2 of 10 (20%) patients with autoimmune liver disease and 1 of 14 (7%) patients with autoimmune liver disease plus non-alcoholic fatty liver disease [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Narkewicz et al characterized 63 children with acute liver failure caused by AIH and found LKM antibodies in 15 of them (24%), 12 having LKM alone, 3 LKM and ANA, and 2 LKM and smooth muscle antibodies [ 6 ]. Muratori et al studied 21 patients with type 2 AIH and demonstrated that 7 of those were positive for LKM1 (33%), 9 for LC1 and 5 for both [ 13 ]. More recently, Khayat et al found LKM antibodies in 2 of 10 (20%) patients with autoimmune liver disease and 1 of 14 (7%) patients with autoimmune liver disease plus non-alcoholic fatty liver disease [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…The disease is more commonly sporadic but given that AIH type 2 patients are typically children (in contrast to most autoimmune diseases), genetic causes have been investigated. Only a handful of autoimmune diseases are caused by a single gene defect [ 13 ], such as the autoimmune polyglandular syndrome type 1, caused by mutations in the AIRE gene [ 14 ]. This syndrome, characterized by the triad of chronic mucocutaneous candidiasis, hypoparathyroidism, and Addison disease, also features AIH type 2 in about a quarter of the cases [ [15] , [16] , [17] ].…”
Section: Discussionmentioning
confidence: 99%
“…To this purpose, shared protocols are needed to improve patient selection among those presenting with immune dysregulation phenotypes to reach more effective selection criteria [3,4]. Some "red flags" have been proposed based on clinical experience, including multi-organ autoimmune/inflammatory involvement, lymphoproliferative manifestations, presentation in early childhood and refractoriness to conventional therapies [5]; nevertheless, patient selection for further immunological and genetic work-up is still largely at the physician's discretion.…”
Section: Introductionmentioning
confidence: 99%